Insider Transactions in Q2 2022 at Ptc Therapeutics, Inc. (PTCT)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 09
2022
|
Dawn Svoronos |
SELL
Open market or private sale
|
Direct |
738
-2.48%
|
$19,926
$27.2 P/Share
|
|
Jun 09
2022
|
Alethia Young |
BUY
Grant, award, or other acquisition
|
Direct |
5,067
+38.46%
|
-
|
|
Jun 07
2022
|
Stuart Walter Peltz CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Indirect |
407
-1.05%
|
$10,582
$26.83 P/Share
|
|
Apr 19
2022
|
Eric Pauwels CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
822
-1.62%
|
$34,524
$42.52 P/Share
|
|
Apr 19
2022
|
Matthew B. Klein CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
897
-1.56%
|
$37,674
$42.52 P/Share
|
|
Apr 14
2022
|
Stuart Walter Peltz CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Indirect |
82
-0.21%
|
$3,690
$45.28 P/Share
|
|
Apr 13
2022
|
Mark Elliott Boulding EXEC. VP AND CLO |
SELL
Open market or private sale
|
Direct |
2,276
-3.59%
|
$102,420
$45.17 P/Share
|
|
Apr 13
2022
|
Mark Elliott Boulding EXEC. VP AND CLO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,276
+3.47%
|
$25,036
$11.23 P/Share
|
|
Apr 05
2022
|
Mark Elliott Boulding EXEC. VP AND CLO |
SELL
Open market or private sale
|
Direct |
5
-0.01%
|
$225
$45.0 P/Share
|
|
Apr 05
2022
|
Mark Elliott Boulding EXEC. VP AND CLO |
BUY
Exercise of conversion of derivative security
|
Direct |
5
+0.01%
|
$55
$11.23 P/Share
|